Hypoglycemia, its implications in clinical practice, and possible ways to prevent it

References

• UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7
   PubMed Web of Science ®Google Scholar
• Seaquist ER, Anderson J, Childs B, et al; American Diabetes Association; Endocrine Society. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab 2013;98:1845-59
   PubMed Web of Science ®Google Scholar
• UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• ; ACCORD Study GroupGerstein HC, Miller ME, Genuth S, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011;364:818-28
   PubMed Web of Science ®Google Scholar
• Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008;24:353-63
   PubMed Web of Science ®Google Scholar
• Judson WE, Hollander W. The effects of insulin-induced hypoglycemia in patients with angina pectoris; before and after intravenous hexamethonium. Am Heart J 1956;52:198-209
   PubMed Web of Science ®Google Scholar
• Marques JL, George E, Peacey SR, et al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet Med 1997;14:648-54
   PubMed Web of Science ®Google Scholar
• Landstedt-Hallin L, Englund A, Adamson U, et al. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med 1999;246:299-307
   PubMed Web of Science ®Google Scholar
• Robinson RT, Harris ND, Ireland RH, et al. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes 2003;52:1469-74
   PubMed Web of Science ®Google Scholar
• Koivikko ML, Karsikas M, Salmela PI, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia 2008;51:426-35
   PubMed Web of Science ®Google Scholar
• Khazai NB, Beck GR, Umpierrez GE. Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diab Obes 2009;16:435-45
   PubMed Web of Science ®Google Scholar
• Stevens JA, Corso PS, Finkelstein EA, et al. The costs of fatal and nonfatal falls among older adults. Inj Prev 2006;12:290-5
   PubMed Web of Science ®Google Scholar
• Bell AJ, Talbot-Stern JK, Hennessy A. Characteristics and outcomes of older patients presenting to the emergency department after a fall: a retrospective analysis. Med J Aust 2000;173:176-7
   PubMed Web of Science ®Google Scholar
• Munshi MN, Segal AR, Suhl E, et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med 2011;171:362-4
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-79
   PubMed Web of Science ®Google Scholar
• Qaseem A, Humphrey LL, Sweet DE, et al. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2012;156:218-31
   PubMed Web of Science ®Google Scholar
• Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009;15:540-59
   PubMed Web of Science ®Google Scholar
• Bron M, Marynchenko M, Yang H, et al. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs. Postgrad Med 2012;124:124-32
   PubMed Web of Science ®Google Scholar
• Ashcroft F. Mechanisms of the glycaemic effects of sulfonylureas. Horm Metab Res 1996;28:456-63
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P. Dipeptidyl peptidase-4 inhibitors: 3 years of experience. Diabetes Technol Ther 2012;14:350-64
   PubMed Web of Science ®Google Scholar
• Mintz ML, Minervini G. Saxagliptin versus glipizide as add-on therapy to metformin: assessment of hypoglycemia. Curr Med Res Opin 2014;30:761-70
   Google Scholar
• Göke B, Gallwitz B, Eriksson J, et al; D1680C00001 Investigators. Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial. Int J Clin Pract 2010;64:1619-31
   PubMed Web of Science ®Google Scholar
• Göke B, Gallwitz B, Eriksson JG, et al. Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial. Int J Clin Pract 2013;67:307-16
   PubMed Web of Science ®Google Scholar
• Sola D, Rossi L, Carnevale Schianca GP, et al. Sulfonylureas and their use in the clinical practice. Arch Med Sci 2013; in press
   Google Scholar
• Holstein A, Hammer C, Hahn M, et al. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatrics patients. Expert Opin Drug Saf 2010;9:675-81
   PubMed Web of Science ®Google Scholar
• Derosa G, Cicero AF, Franzetti IG, et al. A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy. Diabet Med 2013;30:846-54
   PubMed Web of Science ®Google Scholar
• Derosa G, Cicero AF, Fogari E, et al. Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load. Horm Metab Res 2011;43:505-12
   PubMed Web of Science ®Google Scholar